ANATOMICAL PATHOLOGYReagents

Vitro develops, produces and markets a full range of products to diagnose cancer and other diseases

bt_bb_section_bottom_section_coverage_image

ANATOMICAL PATHOLOGYReagents

Improve the efficiency of cancer diagnosis processes

The overall annual incidence of cancer varies widely depending on factors such as geographic location, population demographics, lifestyle factors and access to care. According to estimates by the International Agency for Research on Cancer (IARC), approximately 19.3 million new cases of cancer are diagnosed worldwide every year. The most frequently diagnosed cancers worldwide include lung cancer, breast cancer, colorectal cancer, prostate cancer and stomach cancer. However, the specific types of cancer and their incidence rates can vary widely between different regions and populations.

It is important to note that cancer incidence rates may change over time due to a variety of factors, including changes in risk factors, improvements in cancer detection and diagnosis, and the implementation of cancer screening and prevention programmes. For this reason, early diagnosis of cancer is becoming increasingly important because it can improve treatment outcomes and increase the chances of being cured.

Vitro develops, produces and markets a full range of diagnostic products with a focus on quality, accuracy and the ability to improve the efficiency of diagnostic processes.

Vitro provides anatomical pathologists and other healthcare professionals with reliable and effective tools to make accurate assessments and diagnoses, impacting on treatment and clinical management decisions for each patient.

bt_bb_section_top_section_coverage_image

EXCELLENCE INVitro advanced-staining solution

Optimises the laboratory’s resources

Our comprehensive anatomical pathology solution is backed up by a team of pathologists and experts who remain at the forefront of science, diagnostics and technological developments, providing our customers with a range of state-of-the-art products to meet new challenges.

Our wide range of high-quality reagents and kits and fully automated assays that employ techniques such as histochemistry (HC), immunohistochemistry (IHC), immunofluorescence (IF) and in situ hybridisation (ISH) optimise the laboratory’s day-to-day work, improving efficiency and reducing errors.

The largest range of ready-to-use antibodies
Fully automated system for IHC and in situ hybridisation
Comprehensive diagnostic data management software